1. Palbociclib Induces Senescence in Melanoma and Breast Cancer Cells and Leads to Additive Growth Arrest in Combination With Irradiation
   Tina Jost et al, 2021, Frontiers in Oncology CrossRef
2. Kinase inhibitors increase individual radiation sensitivity in normal cells of cancer patients
   Tina Jost et al, 2022, Strahlentherapie und Onkologie CrossRef
3. Current trends and future prospects of drug repositioning in gastrointestinal oncology
   Nayeralsadat Fatemi et al, 2024, Frontiers in Pharmacology CrossRef
4. The Anti-Angiogenic Effects of Anti-Human Immunodeficiency Virus Drugs
   Giovanni Barillari, 2020, Frontiers in Oncology CrossRef
5. The Antiviral Drug Efavirenz in Breast Cancer Stem Cell Therapy
   Pey-Tsyr Chiou et al, 2021, Cancers CrossRef
6. PARP Inhibitors Talazoparib and Niraparib Sensitize Melanoma Cells to Ionizing Radiation
   Stephanie Jonuscheit et al, 2021, Genes CrossRef
7. Efavirenz and Lopinavir/Ritonavir Alter Cell Cycle Regulation in Lung Cancer
   Rahaba Marima et al, 2020, Frontiers in Oncology CrossRef
8. Efavirenz as a potential drug for the treatment of triple-negative breast cancers
   P.-T. Chiou et al, 2021, Clinical and Translational Oncology CrossRef
9. Drug Repositioning: A Monetary Stratagem to Discover a New Application of Drugs
   Ankur Rohilla et al, 2024, Current Drug Discovery Technologies CrossRef
10. Kinase Inhibitors of DNA-PK, ATM and ATR in Combination with Ionizing Radiation Can Increase Tumor Cell Death in HNSCC Cells While Sparing Normal Tissue Cells
    Eva-Maria Faulhaber et al, 2021, Genes CrossRef
11. Dual mTOR/DNA-PK Inhibitor CC-115 Induces Cell Death in Melanoma Cells and Has Radiosensitizing Potential
    Felix Bürkel et al, 2020, International Journal of Molecular Sciences CrossRef
12. Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?
    Christina Pfab et al, 2021, Cancers CrossRef
13. Efavirenz induces DNA damage response pathway in lung cancer
    Rahaba Marima et al, 2020, Oncotarget CrossRef
14. Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates
    Laura De Lellis et al, 2021, Cancers CrossRef